Cabaletta Bio, Inc. (CABA) - Earnings growth in current year
Cabaletta Bio, Inc. (CABA) is implementing its unique CARTA technology for the targeted elimination of pathogenic B-cells, while its operating model is based on the full outsourcing of production and trials. The EPS growth trend compared to last year on this GURU.Markets platform chart shows that 39.80 is the current value of the indicator. However, investors should consider the risks of FDA regulatory restrictions and dangerous side effects of the therapy.
Financial and market metric breakdowns for Cabaletta Bio, Inc. (CABA)
- price and consensus price forecast:
- market capitalization indicators:
- book capitalization data:
- debt and liquidity details:
Total Debt to Equity Ratio Cabaletta Bio, Inc.|CABA - Long-Term Debt to Capital|Short-Term Debt to Capital cabalettabio.com|CABA - Company Aggregate Debts|Debt to Book Capitalization Ratio Cabaletta Bio Inc|CABA - Company Long-Term Debts|Company Short-Term Debts Cabaletta Bio, Inc.|Quick Liquidity cabalettabio.com
- earnings and market ratios statistics:
CABA - Net Profit|Expected Net Profit Cabaletta Bio, Inc.|CABA - Price to Earnings Ratio|Market Cap to Future Earnings Ratio Cabaletta Bio Inc|CABA - Price/Earnings to Growth Multiple|Enterprise Value to Operating Income Before Depreciation Ratio Cabaletta Bio Inc|CABA - Operating profit EBITDA|Net earnings per share (EPS TTM) Cabaletta Bio, Inc.|CABA - Net earnings per share for the last 12 months|Year-over-year earnings per one share growth for the last 12 months cabalettabio.com|CABA - Earnings growth in current year|Net earnings per share growth forecast for next year Cabaletta Bio, Inc.
Fundamental valuation:Cabaletta Bio Inc., CABA
This indicator measures the year-over-year dynamics of earnings per share, reflecting the rate of change in the business's actual profitability. For Cabaletta Bio, Inc. (CABA), which invests in a cell therapy platform for rare pathologies, the annual EPS growth rate allows for an assessment of R&D cost management efficiency and the impact of pipeline diversification on the company's financial stability during periods of high volatility.
Direct competitors
Net earnings per share growth this year argenx N.V.|Net earnings per share growth this year BNTX|Earnings growth in current year abivax.com|Earnings per share growth in current year ADMA Biologics (ADMA)|protagonist-inc.com - Earnings per share growth this year|Earnings growth in current year IMVT (Immunovant)|Kiniksa Pharmaceuticals, Ltd. (KNSA) - Earnings per share growth rate in current year|Grifols Group - Earnings growth in current year|Adaptive Biotechnologies Inc. (ADPT) - Net earnings per share growth this year|CLDX: Earnings growth in current year|auriniapharma.com (AUPH) - Earnings growth in current year|BCRX (BioCryst Pharmaceuticals) - Earnings growth in current year|Earnings per share growth in current year VERA|Earnings growth in current year DNTH|Earnings growth in current year Pharvaris Pharma (PHVS)|Earnings per share growth in current year AbCellera Biologics ABCL|tourmalinebio.com - Earnings per share growth in current year|Precigen - Earnings growth in current year|Earnings per share growth rate in current year Pharming Group NV|NKTR (Nektar) - Net earnings per share growth this year|UPB: Net earnings per one share growth for the current year|Net earnings per share growth this year ZBIO|IMNM (immunome.com) - Net earnings per one share growth for the current year|Earnings growth in current year GOSS|Earnings growth in current year KalVista Pharma (KALV)|Septerna Corp - Net earnings per share growth this year|Earnings per share increase in current year PVLA|Savara Inc. - Earnings growth in current year|RIGL: Earnings per share growth in current year|ANAB: Earnings growth in current year|ATXS - Expected net earnings per share growth this year|Earnings per share growth in current year enGene Bio|Earnings per share growth rate in current year RAPT Therapeutics Inc. RAPT|Net earnings per share growth this year JBIO (Aerovate Therapeutics Inc)|ACRS (aclaristx.com) - Earnings per share increase in current year|Earnings growth in current year KYTX (Kyverna Therapeutics, Inc.)|Expected net earnings per share growth this year Tiziana Life Sciences Ltd. (TLSA)|VTYX - Earnings per share growth in current year|THTX (Theratechnologies, Inc) - Earnings per share growth this year|AVTX: Earnings growth in current year|Net earnings per share growth this year eledon.com|Net earnings per share growth this year AGEN|Climb Bio Inc. (CLYM) - Expected net earnings per share growth this year|Earnings growth in current year ZURA|Net earnings per share growth this year aTyr Pharmaceuticals ATYR|Earnings growth in current year ADAG (Adagene Inc.)|Earnings growth in current year ImageneBio IMA|Shattuck Therapeutics - Earnings growth in current year|EQ: Earnings per share growth in current year|CNTB: Earnings growth in current year|Immunic (IMUX) - Earnings growth in current year|Earnings per share growth in current year Atara Biotherapeutics, Inc.|InflaRx GmbH - Earnings per share trend in current year|Earnings growth in current year XFOR|ACET (adicetbio.com) - Earnings per share increase in current year|Earnings growth in current year CELU (Celularity)|Earnings growth in current year INmune Bio Corporation INMB|BRNS - Earnings per share growth in current year|Earnings per share increase in current year KZR (kezarlifesciences.com)|SAB Biotherapeutics, Inc. (SABS) - Earnings per share growth in current year|Net earnings per share growth this year Akari Therapeutics PLC|ENLV (Enlivex Therapeutics Ltd) - Earnings growth in current year|Earnings growth in current year Q32 Bio Corp|Net earnings per share growth this year GOVX (GeoVax Labs, Inc.)|EDSA (edesabiotech.com) - Earnings per share increase in current year|Earnings growth in current year IBIO (iBio)|Expected net earnings per share growth this year Carisma Therapeutics Inc (CARM)|XTLB - Earnings per share growth in current year|Bolt Biotherapeutics (BOLT) - Net earnings per share growth this year|hcwbiologics.com (HCWB) - Earnings per share growth in current year|Net earnings per share growth this year Aptevo Therapeutics Inc.|Net earnings per share growth this year AIM|Earnings growth in current year Aditxt Corp|Earnings per share growth in current year GRI Bio Corp (GRI)|XORTX Corp - Earnings per share growth this year|Earnings growth in current year HIND (Vyome Holdings Inc)|revbiosciences.com (REVB) - Earnings per share growth rate in current year|Indaptus Therapeutics, Inc. - Earnings growth in current year|Scinai Immunotherapeutics Ltd (SCNI) - Net earnings per share growth this year|CALI: Earnings growth in current year|Affimed N.V. (AFMD) - Earnings growth in current year|ALLK (Allakos Inc) - Earnings growth in current year|Earnings per share growth in current year HOOK|Earnings growth in current year IGMS|Earnings growth in current year iTeos Therapeutics Inc (ITOS)|Earnings per share growth in current year Ocean Bio OCEA|TC BioPharm Ltd - Earnings per share growth in current year|Third Harmonic Bio - Earnings growth in current year
